ICON PLC (ICLR) Stock Fundamental Analysis

NASDAQ:ICLR • IE0005711209

99.7 USD
+1.29 (+1.31%)
At close: Feb 20, 2026
99.7 USD
0 (0%)
After Hours: 2/20/2026, 5:40:54 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Analyst Ratings Earnings Estimates Financials Ownership News
Fundamental Rating

5

Taking everything into account, ICLR scores 5 out of 10 in our fundamental rating. ICLR was compared to 58 industry peers in the Life Sciences Tools & Services industry. ICLR has only an average score on both its financial health and profitability. ICLR scores decently on growth, while it is valued quite cheap. This could make an interesting combination.


Dividend Valuation Growth Profitability Health

6

1. Profitability

1.1 Basic Checks

  • ICLR had positive earnings in the past year.
  • ICLR had a positive operating cash flow in the past year.
  • In the past 5 years ICLR has always been profitable.
  • In the past 5 years ICLR always reported a positive cash flow from operatings.
ICLR Yearly Net Income VS EBIT VS OCF VS FCFICLR Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B

1.2 Ratios

  • With a decent Return On Assets value of 3.63%, ICLR is doing good in the industry, outperforming 75.86% of the companies in the same industry.
  • The Return On Equity of ICLR (6.42%) is better than 75.86% of its industry peers.
  • The Return On Invested Capital of ICLR (6.74%) is better than 77.59% of its industry peers.
  • Measured over the past 3 years, the Average Return On Invested Capital for ICLR is significantly below the industry average of 12.04%.
  • The 3 year average ROIC (5.80%) for ICLR is below the current ROIC(6.74%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 3.63%
ROE 6.42%
ROIC 6.74%
ROA(3y)3.74%
ROA(5y)4.36%
ROE(3y)6.96%
ROE(5y)8.15%
ROIC(3y)5.8%
ROIC(5y)6.92%
ICLR Yearly ROA, ROE, ROICICLR Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 5 10 15 20 25

1.3 Margins

  • ICLR has a better Profit Margin (7.40%) than 75.86% of its industry peers.
  • ICLR's Profit Margin has declined in the last couple of years.
  • With a decent Operating Margin value of 13.99%, ICLR is doing good in the industry, outperforming 74.14% of the companies in the same industry.
  • In the last couple of years the Operating Margin of ICLR has remained more or less at the same level.
  • Looking at the Gross Margin, with a value of 28.15%, ICLR is doing worse than 77.59% of the companies in the same industry.
  • ICLR's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 13.99%
PM (TTM) 7.4%
GM 28.15%
OM growth 3Y9.91%
OM growth 5Y-0.95%
PM growth 3Y50.65%
PM growth 5Y-6.44%
GM growth 3Y2.3%
GM growth 5Y-0.09%
ICLR Yearly Profit, Operating, Gross MarginsICLR Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 10 20 30 40

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

4

2. Health

2.1 Basic Checks

  • With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), ICLR is destroying value.
  • The number of shares outstanding for ICLR has been reduced compared to 1 year ago.
  • ICLR has more shares outstanding than it did 5 years ago.
  • Compared to 1 year ago, ICLR has an improved debt to assets ratio.
ICLR Yearly Shares OutstandingICLR Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M
ICLR Yearly Total Debt VS Total AssetsICLR Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 5B 10B 15B

2.2 Solvency

  • ICLR has an Altman-Z score of 1.56. This is a bad value and indicates that ICLR is not financially healthy and even has some risk of bankruptcy.
  • ICLR has a Altman-Z score (1.56) which is comparable to the rest of the industry.
  • The Debt to FCF ratio of ICLR is 3.53, which is a good value as it means it would take ICLR, 3.53 years of fcf income to pay off all of its debts.
  • ICLR has a Debt to FCF ratio of 3.53. This is in the better half of the industry: ICLR outperforms 79.31% of its industry peers.
  • ICLR has a Debt/Equity ratio of 0.31. This is a healthy value indicating a solid balance between debt and equity.
  • ICLR's Debt to Equity ratio of 0.31 is in line compared to the rest of the industry. ICLR outperforms 48.28% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.31
Debt/FCF 3.53
Altman-Z 1.56
ROIC/WACC0.77
WACC8.7%
ICLR Yearly LT Debt VS Equity VS FCFICLR Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B 8B

2.3 Liquidity

  • ICLR has a Current Ratio of 1.06. This is a normal value and indicates that ICLR is financially healthy and should not expect problems in meeting its short term obligations.
  • The Current ratio of ICLR (1.06) is worse than 82.76% of its industry peers.
  • A Quick Ratio of 1.06 indicates that ICLR should not have too much problems paying its short term obligations.
  • With a Quick ratio value of 1.06, ICLR is not doing good in the industry: 77.59% of the companies in the same industry are doing better.
Industry RankSector Rank
Current Ratio 1.06
Quick Ratio 1.06
ICLR Yearly Current Assets VS Current LiabilitesICLR Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

4

3. Growth

3.1 Past

  • The earnings per share for ICLR have decreased by -5.99% in the last year.
  • ICLR shows quite a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 15.23% yearly.
  • Looking at the last year, ICLR shows a decrease in Revenue. The Revenue has decreased by -2.46% in the last year.
  • ICLR shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 24.17% yearly.
EPS 1Y (TTM)-5.99%
EPS 3Y13.76%
EPS 5Y15.23%
EPS Q2Q%-1.19%
Revenue 1Y (TTM)-2.46%
Revenue growth 3Y14.75%
Revenue growth 5Y24.17%
Sales Q2Q%0.63%

3.2 Future

  • Based on estimates for the next years, ICLR will show a small growth in Earnings Per Share. The EPS will grow by 5.45% on average per year.
  • Based on estimates for the next years, ICLR will show a small growth in Revenue. The Revenue will grow by 2.44% on average per year.
EPS Next Y-4.71%
EPS Next 2Y-1.84%
EPS Next 3Y2.13%
EPS Next 5Y5.45%
Revenue Next Year-2.43%
Revenue Next 2Y-1.11%
Revenue Next 3Y0.75%
Revenue Next 5Y2.44%

3.3 Evolution

  • The EPS growth rate is decreasing: in the next years the growth will be less than in the last years.
  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
ICLR Yearly Revenue VS EstimatesICLR Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 2B 4B 6B 8B 10B
ICLR Yearly EPS VS EstimatesICLR Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 10 20 30

More info and screens

Find the best growth stocksShow best growing peers

8

4. Valuation

4.1 Price/Earnings Ratio

  • With a Price/Earnings ratio of 7.56, the valuation of ICLR can be described as very cheap.
  • Based on the Price/Earnings ratio, ICLR is valued cheaper than 98.28% of the companies in the same industry.
  • ICLR's Price/Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 26.99.
  • Based on the Price/Forward Earnings ratio of 7.39, the valuation of ICLR can be described as very cheap.
  • ICLR's Price/Forward Earnings ratio is rather cheap when compared to the industry. ICLR is cheaper than 98.28% of the companies in the same industry.
  • When comparing the Price/Forward Earnings ratio of ICLR to the average of the S&P500 Index (28.06), we can say ICLR is valued rather cheaply.
Industry RankSector Rank
PE 7.56
Fwd PE 7.39
ICLR Price Earnings VS Forward Price EarningsICLR Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

  • 98.28% of the companies in the same industry are more expensive than ICLR, based on the Enterprise Value to EBITDA ratio.
  • Based on the Price/Free Cash Flow ratio, ICLR is valued cheaper than 98.28% of the companies in the same industry.
Industry RankSector Rank
P/FCF 7.9
EV/EBITDA 6.87
ICLR Per share dataICLR EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 50 100

4.3 Compensation for Growth

  • ICLR has a very decent profitability rating, which may justify a higher PE ratio.
PEG (NY)N/A
PEG (5Y)0.5
EPS Next 2Y-1.84%
EPS Next 3Y2.13%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. Dividend

5.1 Amount

  • ICLR does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

ICON PLC

NASDAQ:ICLR (2/20/2026, 5:40:54 PM)

After market: 99.7 0 (0%)

99.7

+1.29 (+1.31%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryLife Sciences Tools & Services
Earnings (Last)10-22
Earnings (Next)02-25
Inst Owners105.53%
Inst Owner Change5.2%
Ins Owners0.66%
Ins Owner ChangeN/A
Market Cap7.61B
Revenue(TTM)8.10B
Net Income(TTM)599.48M
Analysts74.17
Price Target209.67 (110.3%)
Short Float %3.73%
Short Ratio1.64
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-0.77%
Min EPS beat(2)-1.21%
Max EPS beat(2)-0.34%
EPS beat(4)1
Avg EPS beat(4)-0.63%
Min EPS beat(4)-1.21%
Max EPS beat(4)0.23%
EPS beat(8)1
Avg EPS beat(8)-2.34%
EPS beat(12)2
Avg EPS beat(12)-1.79%
EPS beat(16)5
Avg EPS beat(16)-1.4%
Revenue beat(2)1
Avg Revenue beat(2)0.4%
Min Revenue beat(2)-0.23%
Max Revenue beat(2)1.03%
Revenue beat(4)1
Avg Revenue beat(4)-0.84%
Min Revenue beat(4)-2.61%
Max Revenue beat(4)1.03%
Revenue beat(8)1
Avg Revenue beat(8)-2.24%
Revenue beat(12)1
Avg Revenue beat(12)-2.14%
Revenue beat(16)1
Avg Revenue beat(16)-2.06%
PT rev (1m)0%
PT rev (3m)-1.36%
EPS NQ rev (1m)0.02%
EPS NQ rev (3m)-0.03%
EPS NY rev (1m)-0.02%
EPS NY rev (3m)-0.04%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-0.05%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0.02%
Valuation
Industry RankSector Rank
PE 7.56
Fwd PE 7.39
P/S 0.94
P/FCF 7.9
P/OCF 6.68
P/B 0.82
P/tB N/A
EV/EBITDA 6.87
EPS(TTM)13.19
EY13.23%
EPS(NY)13.49
Fwd EY13.53%
FCF(TTM)12.63
FCFY12.66%
OCF(TTM)14.93
OCFY14.98%
SpS106.11
BVpS122.25
TBVpS-38.98
PEG (NY)N/A
PEG (5Y)0.5
Graham Number190.47
Profitability
Industry RankSector Rank
ROA 3.63%
ROE 6.42%
ROCE 8.53%
ROIC 6.74%
ROICexc 6.98%
ROICexgc 176.34%
OM 13.99%
PM (TTM) 7.4%
GM 28.15%
FCFM 11.9%
ROA(3y)3.74%
ROA(5y)4.36%
ROE(3y)6.96%
ROE(5y)8.15%
ROIC(3y)5.8%
ROIC(5y)6.92%
ROICexc(3y)5.97%
ROICexc(5y)8.67%
ROICexgc(3y)88.82%
ROICexgc(5y)90.84%
ROCE(3y)7.34%
ROCE(5y)8.76%
ROICexgc growth 3Y-4.45%
ROICexgc growth 5Y-5.01%
ROICexc growth 3Y27.99%
ROICexc growth 5Y-24.17%
OM growth 3Y9.91%
OM growth 5Y-0.95%
PM growth 3Y50.65%
PM growth 5Y-6.44%
GM growth 3Y2.3%
GM growth 5Y-0.09%
F-Score6
Asset Turnover0.49
Health
Industry RankSector Rank
Debt/Equity 0.31
Debt/FCF 3.53
Debt/EBITDA 1.89
Cap/Depr 45.31%
Cap/Sales 2.17%
Interest Coverage 250
Cash Conversion 74.92%
Profit Quality 160.84%
Current Ratio 1.06
Quick Ratio 1.06
Altman-Z 1.56
F-Score6
WACC8.7%
ROIC/WACC0.77
Cap/Depr(3y)27.79%
Cap/Depr(5y)38.09%
Cap/Sales(3y)1.87%
Cap/Sales(5y)1.83%
Profit Quality(3y)130.43%
Profit Quality(5y)205.36%
High Growth Momentum
Growth
EPS 1Y (TTM)-5.99%
EPS 3Y13.76%
EPS 5Y15.23%
EPS Q2Q%-1.19%
EPS Next Y-4.71%
EPS Next 2Y-1.84%
EPS Next 3Y2.13%
EPS Next 5Y5.45%
Revenue 1Y (TTM)-2.46%
Revenue growth 3Y14.75%
Revenue growth 5Y24.17%
Sales Q2Q%0.63%
Revenue Next Year-2.43%
Revenue Next 2Y-1.11%
Revenue Next 3Y0.75%
Revenue Next 5Y2.44%
EBIT growth 1Y-0.88%
EBIT growth 3Y26.12%
EBIT growth 5Y22.99%
EBIT Next Year1.2%
EBIT Next 3Y1.67%
EBIT Next 5Y3.12%
FCF growth 1Y86.71%
FCF growth 3Y15.01%
FCF growth 5Y25.32%
OCF growth 1Y72.39%
OCF growth 3Y15.78%
OCF growth 5Y25.55%

ICON PLC / ICLR FAQ

Can you provide the ChartMill fundamental rating for ICON PLC?

ChartMill assigns a fundamental rating of 5 / 10 to ICLR.


What is the valuation status for ICLR stock?

ChartMill assigns a valuation rating of 8 / 10 to ICON PLC (ICLR). This can be considered as Undervalued.


How profitable is ICON PLC (ICLR) stock?

ICON PLC (ICLR) has a profitability rating of 6 / 10.


What is the valuation of ICON PLC based on its PE and PB ratios?

The Price/Earnings (PE) ratio for ICON PLC (ICLR) is 7.56 and the Price/Book (PB) ratio is 0.82.


How financially healthy is ICON PLC?

The financial health rating of ICON PLC (ICLR) is 4 / 10.